Related references
Note: Only part of the references are listed.
Article
Multidisciplinary Sciences
Barbara A. Cohn et al.
Summary: This study reports the effectiveness of vaccines against SARS-CoV-2 infection and death in veterans, with a decline in vaccine effectiveness observed for all vaccine types. The decline was greatest for the Janssen vaccine. However, vaccination remained protective against death for individuals who became infected during the Delta variant surge. The study also found variations in the vaccine effectiveness against death among different age groups.
Article
Multidisciplinary Sciences
Daniel Mrak et al.
Summary: Optimizing COVID-19 vaccination strategies for immunosuppressed patients is crucial. In this clinical trial, a homologous mRNA booster vaccine showed higher seroconversion rate compared to a switch to a vector-based vaccine for non-seroconverted immunosuppressed patients. The study highlights the importance of booster vaccination and supports the use of homologous mRNA booster vaccine in this vulnerable group.
NATURE COMMUNICATIONS
(2022)
Review
Allergy
Ya-dong Gao et al.
Summary: The severity factors of COVID-19 include age, gender, underlying health conditions such as hypertension, diabetes, obesity, and immunodeficiency, which may lead to complications like acute kidney injury. Various laboratory indicators and parameters can help monitor disease progression, while socioeconomic factors, lifestyle, and quality of healthcare also play a role in individual outcomes.
Article
Multidisciplinary Sciences
Kate M. Bubar et al.
Summary: The study found that prioritizing the vaccine for adults aged 20 to 49 can minimize the number of cases, while prioritizing the vaccine for adults over 60 can minimize mortality and years of life lost. Redirecting vaccine doses to seronegative individuals through individual-level serological tests can improve the impact of each dose.
Article
Multidisciplinary Sciences
Cecile Tran Kiem et al.
Summary: This study demonstrates that without vaccines, COVID-19 transmission risk involves all age groups. Protecting older individuals is not enough to relax general social distancing measures, and addressing the pandemic requires efforts from all age groups.
NATURE COMMUNICATIONS
(2021)
Article
Infectious Diseases
Ze-yu Zhao et al.
Summary: This study developed an age-specific model based on the current transmission patterns of COVID-19 in Wuhan City to simulate the optimal vaccination strategy. The results emphasize the importance of vaccinating at least 85% of the total population and prioritizing vaccination for age group 2, among other key recommendations.
INFECTIOUS DISEASES OF POVERTY
(2021)
Article
Biochemical Research Methods
Sam Moore et al.
Summary: The COVID-19 outbreak has shown the vulnerability to novel infections and the UK, like many other countries, enforced social distancing measures to reduce transmission. Vaccination is seen as the only way to contain the infection and return to normalcy, with targeting older age groups first being considered optimal. This vaccination strategy is crucial in reducing mortality and healthcare demands, but success is dependent on vaccine characteristics and population uptake.
PLOS COMPUTATIONAL BIOLOGY
(2021)
Article
Multidisciplinary Sciences
Shasha Han et al.
Summary: The dynamic allocation of COVID-19 vaccines according to the evolving epidemiological situation is crucial in reducing the burden of COVID-19. Increasing vaccination capacity, especially in the early phase of vaccination campaigns, can significantly mitigate the impact of COVID-19.
NATURE COMMUNICATIONS
(2021)
Article
Multidisciplinary Sciences
Laura Matrajt et al.
Summary: The optimal allocation strategy for COVID-19 vaccines, whether single-dose or two-dose, depends on the transmission rate and vaccine efficacy. In low transmission scenarios, single-dose vaccination is optimal with high efficacy, while in high transmission scenarios, prioritizing older adults for two doses is the best strategy to prevent more deaths.
NATURE COMMUNICATIONS
(2021)
Review
Infectious Diseases
Eun Bi Noh et al.
Summary: Thirteen studies were reviewed, and it was found that older adults and healthcare workers were the most frequently mentioned groups. The most commonly mentioned goal was reducing severe COVID-19 cases.
INFECTION AND CHEMOTHERAPY
(2021)
Article
Multidisciplinary Sciences
Laura Matrajt et al.
Summary: Vaccines are expected to be the best tool for controlling the COVID-19 pandemic, with high effectiveness paired with high coverage able to significantly mitigate the pandemic. Vaccine allocation strategies may vary based on vaccine effectiveness, with high-risk age groups prioritized for low effectiveness vaccines, and high-transmission age groups prioritized for high effectiveness vaccines.
Article
Multidisciplinary Sciences
Juanjuan Zhang et al.
Article
Infectious Diseases
Ze-Yu Zhao et al.
INFECTIOUS DISEASES OF POVERTY
(2020)
